Hepatitis C
Hepatitis C is a virus that can infect the liver. Left untreated, it can cause serious and life-threatening damage to the liver over many years.
A silent Killer
Hepatitis C
Hepatitis C is an inflammation of the liver caused by the Hepatitis C Virus (HCV). The infection can cause chronic, often fatal conditions. Globally, an estimated 58 million people have chronic HCV infection, with about 1.5 million new infections and 300,000 deaths occurring per year. The burden is thought to be highest in Europe and the Eastern Mediterranean regions.
Anti-viral medicines can cure more than 95% of people with hepatitis C, but access to diagnosis and treatment is low.
SwiftDx
Hepatitis C Rapid Detection
Need for Rapid Diagnostics
Both the Global Fund and WHO have recently called for increased access to HCV diagnostics with particular emphasis on self-testing. Through the COVID-19 pandemic, self-testing has become universally accepted
Current Rapid Diagnostics
Current rapid point-of-need tests are not sensitive enough to detect the disease without the need to collect relatively large capillary blood samples, requiring a healthcare professional to perform the test. SwiftDx eAMP technology will allow HCV detection through simple-to-collect saliva samples
HCV testing Market
The global HCV testing market is thought to be worth around USD 1.3B and is expected to grow to USD 2.3B in 2031, dominated by immunoassays
SwiftDx Solution
The SwiftDx HCV Saliva test will be an ultra-boosted sensitivity HCV diagnostic test for saliva samples. We will leverage shortened global market access evaluation processes.
A saliva test will be easy to use and highly sensitive, allowing it to be effectively used as a self-test in both direct to consumer and programmatic delivery.